×
Stock Screener
Stock Research
Top Dividend Stocks
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Economy
Cullinan Therapeutics Income Statement 2019-2025 | CGEM
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Income Statement
Balance Sheet
Cash Flow Statement
Key Financial Ratios
Format: Annual
Format: Quarterly
Format: Annual
View Annual Reports
Loading...
Annual Data | Millions of US $ except per share data
2024-12-31
2023-12-31
2022-12-31
2021-12-31
2020-12-31
2019-12-31
Revenue
-
-
-
$18.943
-
-
Cost Of Goods Sold
-
-
-
-
-
-
Gross Profit
-
-
-
$18.943
-
-
Research And Development Expenses
$142.903
$148.156
$91.948
$57.751
$43.211
$16.788
SG&A Expenses
$54.016
$42.493
$40.189
$29.146
$17.124
$5.482
Other Operating Income Or Expenses
-
$-0.44
$276.785
-
-
-
Operating Expenses
-
-
-
-
-
-
Operating Income
$-196.919
$-191.089
$144.648
$-67.954
$-60.335
$-22.27
Total Non-Operating Income/Expense
$29.461
$21.866
$6.668
$0.469
$0.877
$0.616
Pre-Tax Income
$-167.458
$-169.223
$151.316
$-67.485
$-59.458
$-21.654
Income Taxes
$0.117
$-14.122
$42.121
-
-
-
Income After Taxes
$-167.575
$-155.101
$109.195
$-67.485
$-59.458
$-21.654
Other Income
-
-
-
-
-
-
Income From Continuous Operations
$-167.575
$-155.101
$109.195
$-67.485
$-59.458
$-21.654
Income From Discontinued Operations
-
-
-
-
-
-
Net Income
$-167.383
$-153.162
$111.214
$-65.57
$-51.799
$-20.657
EBITDA
$-196.613
$-190.779
$144.741
$-67.901
$-60.273
$-22.2
EBIT
$-196.919
$-191.089
$144.648
$-67.954
$-60.335
$-22.27
Basic Shares Outstanding
54
42
45
43
20
6
Shares Outstanding
54
42
47
43
20
6
Basic EPS
$-2.78
$-3.21
$2.46
$-1.52
$-2.60
$-3.23
EPS - Earnings Per Share
$-2.78
$-3.21
$2.38
$-1.52
$-2.60
$-3.23
www.jqwidgets.com